Incyte (INCY) Construction in Progress (2019 - 2022)

Incyte (INCY) reported Construction in Progress of $176.2 million for Q4 2022, down 10.74% on a YoY basis from $197.4 million in Q4 2021, and down 10.74% quarter-over-quarter from $197.4 million in Q4 2021.

Incyte (INCY) Construction in Progress (2019 - 2022) Analysis & Trends

Incyte has reported Construction in Progress for 4 years, with the latest figure at $176.2 million in Q4 2022.

  • For the quarter ending Q4 2022, Construction in Progress fell 10.74% year-over-year to $176.2 million; the trailing twelve-month figure through Dec 2022 stood at $176.2 million (down 10.74% YoY), and the FY2022 full-year result was $176.2 million, down 10.74% from the prior year.
  • Construction in Progress for Q4 2022 stood at $176.2 million, down from $197.4 million in the prior quarter.
  • The five-year high for Construction in Progress was $197.4 million in Q4 2021, with the low at $2.0 million in Q1 2019.
  • Historically, Construction in Progress has averaged $63.4 million across 4 years, with a median of $20.8 million in 2020.
  • Annual changes were most pronounced in 2021 — Construction in Progress surged 1002.79% — and 2022, when it fell 10.74%.
  • Incyte's Construction in Progress stood at $13.8 million in 2019, then gained by 29.71% to $17.9 million in 2020, then surged by 1002.79% to $197.4 million in 2021, then slipped by 10.74% to $176.2 million in 2022.
  • The last three Construction in Progress figures came in at $176.2 million (Q4 2022), $197.4 million (Q4 2021), and $140.7 million (Q3 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2022 176.20 Mn
Dec 31, 2021 197.40 Mn
Sep 30, 2021 140.70 Mn
Jun 30, 2021 125.60 Mn
Mar 31, 2021 19.10 Mn
Dec 31, 2020 17.90 Mn
Sep 30, 2020 23.80 Mn
Jun 30, 2020 22.40 Mn
Mar 31, 2020 18.20 Mn
Dec 31, 2019 13.80 Mn
Jun 30, 2019 3.90 Mn
Mar 31, 2019 2.00 Mn